Global Source Ventures investment portfolio
Global Source Ventures, a San Diego-based venture capital firm founded in 2011 specializing in early-stage life sciences investments, has made 14 investments including companies like Filo, SelectION, and VelosBio, with a portfolio of 4 active companies and 9 successful exits such as Avalyn Pharma's IPO in 2026 and Learn In's exit in 2022.
Overview
Global Source Ventures is a venture capital firm founded in 2011 and based in San Diego, California. The firm focuses on early-stage investments, primarily in the life sciences sector. It is actively seeking new investments and has a team of two professionals.
Business Details
- Website: globalsourceventures.com
- Year Founded: 2011
- Investor Status: Actively Seeking New Investments
- Primary Investor Type: Venture Capital
- Corporate Office:
- 655 India Street, Suite 204, San Diego, CA 92101, United States
Investments
Global Source Ventures has made 14 investments, with a portfolio of 4 companies and 9 exits. Some of their notable investments include:
- Filo (Educational and Training Services (B2C)) (Deal Date: 18-Feb-2022, Early Stage VC, Industry: Educational and Training Services (B2C), Company Stage: Generating Revenue)
- SelectION (Deal Date: 08-Apr-2021, Industry: Drug Discovery, Company Stage: Clinical Trials - Phase 1)
- Learn In (Deal Date: 27-Mar-2020, Industry: Educational Software, Company Stage: Generating Revenue)
- Immusoft (Deal Date: 01-Jan-2020, Industry: Drug Discovery, Company Stage: Clinical Trials - Phase 1)
- Soluventis Nanotherapeutics (Deal Date: 01-Jan-2019, Industry: Drug Discovery, Company Stage: Generating Revenue)
- VelosBio (Deal Date: 08-Feb-2018, Industry: Pharmaceuticals, Company Stage: Generating Revenue)
- Avalyn Pharma (Deal Date: 15-Mar-2017, Industry: Drug Discovery, Company Stage: Generating Revenue)
- Telephus Biosciences (Deal Date: 01-Feb-2017, Later Stage VC, Industry: Drug Discovery, Company Stage: Out of Business)
- Zavante (Deal Date: 04-Apr-2016, Early Stage VC, Industry: Biotechnology, Company Stage: Generating Revenue)
Exits
Global Source Ventures has had 9 exits, including:
- Avalyn Pharma (Exit Date: 30-Apr-2026, IPO)
- Learn In (Exit Date: 23-Jun-2022)
- Retrotope (Exit Date: 21-Mar-2022)
- VelosBio (Exit Date: 18-Dec-2020)
- Oncternal Therapeutics (Exit Date: 07-Jun-2019)
- Telephus Biosciences (Exit Date: 25-Feb-2019)
- Zavante (Exit Date: 24-Jul-2018)
- RetroSense Therapeutics (Exit Date: 06-Sep-2016, Merger/Acquisition)
- Afternic.com (Exit Date: 19-Sep-2013, Buyout/LBO)
Co-Investors
Some of the co-investors that have partnered with Global Source Ventures include:
Frequently Asked Questions
What is Global Source Ventures?
Founded in 2011, Global Source Ventures is a venture capital firm based in San Diego, California.
When was Global Source Ventures founded?
Global Source Ventures was founded in 2011.
Where is Global Source Ventures headquartered?
Global Source Ventures is headquartered in San Diego, CA.
How many investments has Global Source Ventures made?
Global Source Ventures has made 14 investments.
What has Global Source Ventures invested in?
Global Source Ventures has made numerous investments in companies like Filo (Educational and Training Services (B2C)), SelectION, and Learn In within the Educational and Training Services (B2C), Drug Discovery, and Educational Software industries.
What has Global Source Ventures invested in recently?
Global Source Ventures's latest investment was on 18-Feb-2022 in Filo (Educational and Training Services (B2C)), a company within the Educational and Training Services (B2C) industry.